Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

TELA Bio Q4 2023 GAAP EPS $(0.53) Misses $(0.44) Estimate, Sales $16.998M Beat $16.392M Estimate

Author: Benzinga Newsdesk | March 21, 2024 04:16pm
TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.44) by 20.45 percent. The company reported quarterly sales of $16.998 million which beat the analyst consensus estimate of $16.392 million by 3.69 percent. This is a 46.26 percent increase over sales of $11.622 million the same period last year.

Posted In: TELA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist